Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone-Reference-Cited by-同舟云学术

Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone

Published:2013-03-14 Issue:11 Volume:54 Page:2412-2417
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Suzuki Kazuhito¹²,Terui Yasuhito¹,Yokoyama Masahiro¹,Ueda Kyoko¹,Nishimura Noriko¹,Mishima Yuko¹,Sakajiri Sakura¹,Tsuyama Naoko³,Takeuchi Kengo⁴,Hatake Kiyohiko¹

Affiliation:

1. Department of Medical Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

2. Department of Clinical Oncology/Hematology, The Jikei University School of Medicine, Tokyo, Japan

3. Department of Pathology

4. Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.779690

Reference31 articles.